Angiotensin-converting enzyme (ACE) inhibitors, such as ramipril, lisinopril, and perindopril, are commonly prescribed for hypertension, heart failure, and chronic kidney disease. Whilst patients occasionally worry about sexual side effects, research indicates that ACE inhibitors generally have a neutral effect on erectile function, unlike some other blood pressure medications. Importantly, hypertension itself significantly increases the risk of erectile dysfunction by damaging blood vessels. Understanding the relationship between ACE inhibitors and sexual health helps patients and clinicians make informed treatment decisions whilst maintaining effective cardiovascular management and quality of life.

Do ACE Inhibitors Cause Erectile Dysfunction?

Angiotensin-converting enzyme (ACE) inhibitors are widely prescribed medications for managing hypertension, heart failure, and chronic kidney disease. Common examples include ramipril, lisinopril, perindopril, and enalapril. These medications work by blocking the conversion of angiotensin I to angiotensin II, thereby reducing blood vessel constriction and lowering blood pressure. Whilst ACE inhibitors are generally well-tolerated, patients occasionally express concerns about potential sexual side effects, particularly erectile dysfunction (ED).

The relationship between ACE inhibitors and erectile dysfunction is complex. Unlike some other antihypertensive medications—particularly beta-blockers and thiazide diuretics—ACE inhibitors are generally considered to have a neutral effect on erectile function. It's worth noting that sexual dysfunction is listed as an uncommon adverse reaction in ACE inhibitor product information, though the overall impact on erectile function is typically less problematic than with some other blood pressure medications.

It is crucial to recognise that hypertension itself is a significant risk factor for erectile dysfunction, independent of treatment. High blood pressure damages the endothelial lining of blood vessels, reducing nitric oxide availability and impairing the vascular mechanisms necessary for achieving and maintaining an erection. Therefore, when ED occurs in men taking ACE inhibitors, it is often attributable to the underlying cardiovascular disease, diabetes, obesity, or other risk factors rather than the medication itself. Understanding this distinction helps patients and clinicians make informed decisions about continuing or modifying antihypertensive therapy whilst addressing sexual health concerns appropriately.

Research Evidence on ACE Inhibitors and Erectile Dysfunction

Clinical studies generally suggest that ACE inhibitors have a relatively favourable profile regarding sexual function when compared to certain other classes of antihypertensive medications, particularly older beta-blockers and thiazide diuretics. Research indicates that ACE inhibitors typically have a neutral effect on erectile function, while angiotensin receptor blockers (ARBs) may have the most consistent evidence for beneficial effects.

The pharmacological mechanism potentially explaining this profile relates to ACE inhibitors' effects on the renin-angiotensin-aldosterone system (RAAS). By reducing angiotensin II levels, ACE inhibitors promote vasodilation and may support endothelial function, which is essential for normal erectile physiology. Additionally, ACE inhibitors increase bradykinin levels, which stimulates nitric oxide production—a key mediator of penile smooth muscle relaxation and blood flow during erection. This contrasts with some beta-blockers, which can reduce cardiac output and peripheral blood flow, and thiazide diuretics, which may affect hormonal balance and vascular function. It's worth noting that certain beta-blockers (such as nebivolol) may have less impact on erectile function than older agents.

Observational studies have not identified a strong association between ACE inhibitor use and new-onset erectile dysfunction. When sexual dysfunction does occur in patients taking ACE inhibitors, it is typically multifactorial, involving contributions from diabetes, obesity, smoking, psychological factors, and the cardiovascular disease itself. The NICE guidelines on hypertension management (NG136) recommend selecting antihypertensive medications based on age, ethnicity, and comorbidities following a stepwise algorithm, while considering individual factors including potential adverse effects on sexual function.

Managing Erectile Dysfunction While Taking ACE Inhibitors

If you experience erectile dysfunction whilst taking an ACE inhibitor, it is important not to discontinue your medication without medical advice, as uncontrolled hypertension poses serious health risks including stroke, heart attack, and kidney damage. Instead, a comprehensive approach to managing ED should be adopted, addressing both cardiovascular health and sexual function simultaneously.

Lifestyle modifications form the cornerstone of managing both hypertension and erectile dysfunction. Evidence-based interventions include:

• Weight loss: Obesity is independently associated with ED; losing 5-10% of body weight can significantly improve erectile function

• Regular physical activity: At least 150 minutes of moderate-intensity exercise weekly improves cardiovascular health and erectile function

• Smoking cessation: Smoking damages blood vessels and is a major modifiable risk factor for ED

• Alcohol moderation: Excessive alcohol consumption impairs sexual function

• Stress management: Psychological factors significantly contribute to ED; cognitive behavioural therapy or mindfulness may help

Pharmacological treatments for erectile dysfunction can generally be used alongside ACE inhibitors, but require appropriate precautions. Phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil, tadalafil, and vardenafil are effective first-line treatments. While generally safe with ACE inhibitors, they may cause a small additional blood pressure-lowering effect, so monitor for dizziness or hypotension. PDE5 inhibitors are strictly contraindicated in men taking nitrate medications (including glyceryl trinitrate and isosorbide mononitrate) and nicorandil due to the risk of severe hypotension. They should also be avoided with riociguat and used with caution alongside alpha-blockers (with appropriate dose separation).

Your GP may also review your complete medication regimen to identify other potential contributors to ED, such as antidepressants, antipsychotics, finasteride, spironolactone, or other cardiovascular medications. Optimising blood pressure control itself often improves erectile function by reducing vascular damage and improving overall cardiovascular health.

When to Speak to Your GP About Sexual Side Effects

Open communication with your GP about sexual side effects is essential for maintaining both cardiovascular health and quality of life. Many men feel embarrassed discussing erectile dysfunction, but it is a common medical concern that GPs are well-equipped to address. Sexual health is an important component of overall wellbeing, and concerns about ED should never be a barrier to effective blood pressure management.

You should arrange an appointment with your GP if you experience:

• New or worsening erectile dysfunction after starting an ACE inhibitor or any other medication

• Persistent ED affecting your quality of life or relationships

• Loss of libido or other changes in sexual function

• Concerns about your blood pressure medication and its potential effects

Seek urgent medical attention if you experience:

• Chest pain or severe breathlessness during sexual activity

• Fainting or severe dizziness

• Sudden neurological symptoms such as facial drooping, arm weakness, or speech difficulties

During your consultation, your GP will take a comprehensive history to identify potential causes of ED, including cardiovascular risk factors, diabetes, hormonal imbalances, psychological factors, and medication effects. A thorough assessment typically includes:

• Review of all current medications and their potential sexual side effects

• Cardiovascular risk assessment and blood pressure control evaluation

• Blood tests to check for diabetes, cholesterol levels, and testosterone (if clinically indicated)

• Assessment of psychological factors such as anxiety, depression, or relationship issues

Your GP can discuss various management options, including lifestyle modifications, switching to alternative antihypertensive medications if appropriate, or prescribing treatments specifically for ED. Referral to a specialist may be warranted if ED is severe, does not respond to first-line treatments, if Peyronie's disease is suspected, if there are hormonal abnormalities, or if you have complex cardiovascular disease.

Remember that erectile dysfunction can be an early warning sign of cardiovascular disease, as the smaller blood vessels in the penis may show damage before larger coronary arteries. If you believe you're experiencing side effects from your medication, you can report these through the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk).

Frequently Asked Questions